Zimmer has received FDA clearance for the TM-S Trabecular Metal cervical interbody fusion device, according to a company news release.
The TM-S system is constructed from the company's Trabecular Metal technology, a porous metal biomaterial with structural and mechanical properties similar to cancellous bone. The material also serves as an osteoconductive scaffold to support bony in-growth and vascularization into the implant.
The TM-S system is intended for use with supplemental fixation systems and with autogenous bone graft. It was designed for patients with degenerative disc disease with or without radicular symptoms at one level from C2-T1.
Read the Zimmer news release on the system for the cervical spine.
Read other coverage on orthopedic and spine device clearances:
- Mazor Robotics Receives FDA Clearance for Emerald Spinal Implant System
- Zyga Technology Receives FDA 510(k) Clearance for Sacroiliac Joint Fusion System
- Small Bone Innovations Receives FDa 510(k) Clearance for rHand Extended Stem
The TM-S system is constructed from the company's Trabecular Metal technology, a porous metal biomaterial with structural and mechanical properties similar to cancellous bone. The material also serves as an osteoconductive scaffold to support bony in-growth and vascularization into the implant.
The TM-S system is intended for use with supplemental fixation systems and with autogenous bone graft. It was designed for patients with degenerative disc disease with or without radicular symptoms at one level from C2-T1.
Read the Zimmer news release on the system for the cervical spine.
Read other coverage on orthopedic and spine device clearances:
- Mazor Robotics Receives FDA Clearance for Emerald Spinal Implant System
- Zyga Technology Receives FDA 510(k) Clearance for Sacroiliac Joint Fusion System
- Small Bone Innovations Receives FDa 510(k) Clearance for rHand Extended Stem